LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 59.42 | 21.74 | 4135 | 6125 | 0.6751 | 0.9057 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 59.42 | 21.74 | 4158 | 6125 | 0.6788 | 0.9070 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 59.42 | 21.74 | 388 | 6125 | 0.0633 | 0.4249 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 59.42 | 21.74 | 4856 | 6125 | 0.7928 | 0.9437 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 62.39 | 21.74 | 4392 | 6112 | 0.7185 | 0.9204 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 62.39 | 21.74 | 4427 | 6112 | 0.7242 | 0.9222 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 62.39 | 21.74 | 4384 | 6112 | 0.7172 | 0.9199 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 62.39 | 21.74 | 4406 | 6112 | 0.7208 | 0.9211 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 62.39 | 21.74 | 370 | 6112 | 0.0605 | 0.4168 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 62.39 | 21.74 | 5114 | 6112 | 0.8366 | 0.9566 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.36 | 21.74 | 4701 | 6191 | 0.7593 | 0.9336 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.36 | 21.74 | 4730 | 6191 | 0.7640 | 0.9351 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.36 | 21.74 | 4619 | 6191 | 0.7461 | 0.9294 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.36 | 21.74 | 4642 | 6191 | 0.7498 | 0.9306 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.36 | 21.74 | 372 | 6191 | 0.0601 | 0.4166 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 64.36 | 21.74 | 5338 | 6191 | 0.8622 | 0.9640 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.33 | 21.74 | 4881 | 6235 | 0.7828 | 0.9409 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.33 | 21.74 | 4918 | 6235 | 0.7887 | 0.9427 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.33 | 21.74 | 4855 | 6235 | 0.7786 | 0.9396 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.33 | 21.74 | 4872 | 6235 | 0.7813 | 0.9405 | MN20160310_N01 | H05 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.33 | 21.74 | 451 | 6235 | 0.0723 | 0.4498 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 66.33 | 21.74 | 5522 | 6235 | 0.8856 | 0.9705 | MN20160310_N01 | I21 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.30 | 21.74 | 5134 | 6244 | 0.8221 | 0.9526 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.30 | 21.74 | 5168 | 6244 | 0.8276 | 0.9542 | MN20160310_N01 | E20 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.30 | 21.74 | 5045 | 6244 | 0.8079 | 0.9484 | MN20160310_N01 | H05 |